Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors
Christopher Heeschen, … , Stefanie Dimmeler, John P. Cooke
Christopher Heeschen, … , Stefanie Dimmeler, John P. Cooke
Published August 15, 2002
Citation Information: J Clin Invest. 2002;110(4):527-536. https://doi.org/10.1172/JCI14676.
View: Text | PDF
Article Vascular biology

A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors

  • Text
  • PDF
Abstract

Research Article

Authors

Christopher Heeschen, Michael Weis, Alexandra Aicher, Stefanie Dimmeler, John P. Cooke

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Expression of nAChR subunits on subconfluent ECs. (a) FACS analysis demo...
Expression of nAChR subunits on subconfluent ECs. (a) FACS analysis demonstrated that the subunits α3, α4, α7, β2, and β4 were expressed on the utilized ECs. Results are shown as box plots displaying 25th and 75th percentiles as boxes and 5th and 95th percentiles as thin lines. n = 4 for each nAChR subunit; *P < 0.01 compared with isotype control. (b) The α7-nAChR was detectable at very low levels on confluent ECs. The expression of α7-nAChR was significantly increased during proliferation (in subconfluent cells), during hypoxia (4 hours), or during stimulation with nicotine (0.1 nM, 12 hours). A representative histogram is shown. GAM/PE, secondary goat anti-mouse antibody labelled with phycoerythrin.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts